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Abstract
Purpose. We set out to determine effectiveness of interventions for improving the quality of services provided by specialized
drug shops in sub-Saharan Africa.
Data sources. We searched PubMed, CAB Abstracts, Web of Science, PsycINFO and Eldis databases and websites for organiz-
ations such as WHO and Management Sciences for Health. Finally, we searched manually through the references of retrieved
articles.
Study selection. Our search strategy included randomized trials, time-series studies and before and after studies evaluating six
interventions; education, peer review, reorganizing administrative structures, incentives, regulation and legislation.
Data extraction. We extracted information on design features, participants, interventions and outcomes assessed studies for
methodological quality, and extracted results, all using uniform checklists.
Results of data synthesis. We obtained 10 studies, all implementing educational interventions. Outcome measures were hetero-
geneous and included knowledge, communication and dispensing practices. Education improved knowledge across studies, but
gave mixed results on communication between sellers and clients, dispensing of appropriate treatments and referring of patients
to health facilities. Proﬁt incentives appeared to constrain behaviour change in certain instances, although cases of shops adopt-
ing practices at the expense of sales revenue were also reported.
Conclusion. Evidence suggests that knowledge and practices of pharmacies and drug shops can be improved across a range of
diseases and countries/regions, although variations were reported across studies. Proﬁt incentives appear to bear some inﬂuence
on the level of success of interventions. More work is required to extend the geographical base of evidence, investigate cost-
effectiveness and evaluate sustainability of interventions over periods longer than 1 year.
Keywords: quality improvement, patient-provider communication/information, developing countries, pharmacy,
training/education
Introduction
Private providers are an increasingly important source of
treatment in developing countries [1, 2], contributing as
much as 80% of health provision in some countries [3] and
absorbing up to 83% of total expenditure on health [4].
Studies have shown them to be common sources of treat-
ment for malaria [5, 6], sexually transmitted infections (STIs)
[7] and acute respiratory infections (ARIs) [8] among others.
Many of these encounters are not with private clinicians, but
with medicine retailers, who are popular for their proximity,
expediency, ﬂexibility in operating hours and responsiveness
to client demands among other reasons [8–10].
Medicine retailers vary across countries, but two main cat-
egories can be identiﬁed; shops that specialize in selling
medicines and those that sell medicines alongside general
International Journal for Quality in Health Care vol. 22 no. 4
# The Author 2010. Published by Oxford University Press in association with the International Society for Quality in Health Care
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly
cited. 316
International Journal for Quality in Health Care 2010; Volume 22, Number 4: pp. 316–323 10.1093/intqhc/mzq022
Advance Access Publication: 29 April 2010household merchandise. We term the former specialized drug
shops (SDSs). We further classify SDSs into four types;
pharmacist-run pharmacies (PRPs), non-PRPs (NPRPs), unre-
gistered drug shops and community-owned drug shops. As
the name suggests, PRPs (commonly referred to as ‘pharma-
cies’) are operated by graduate pharmacists and licensed to sell
both prescription medicines and over-the-counter medicines.
Sub-Saharan Africa (SSA) suffers from very low numbers
of trained pharmacists overall. As a result, pharmacies tend
to be few in number and clustered in larger towns, thus
failing to meet the need for medicines in many rural areas
[11, 12]. Consequently, many countries license non-
pharmacists to operate special cadres of shops (NPRPs) and
dispense a limited range of medicines subject to meeting
certain requirements. However, it is quite common to ﬁnd
these shops selling prescription medicines illegally [13].
Unregistered drug shops are fairly common in SSA [13] and
are categorized separately to differentiate them from the
legally recognized NPRPs. The ﬁnal category consists of
not-for-proﬁt drug shops managed by communities through
revolving funds. NPRPs are commonly referred to as ‘drug
shops’, although the term also refers to unregistered and
community-owned drug shops in some literature.
Pharmacies in SSA tend to be relatively large establish-
ments with several staff, and a wider range of medicines
compared with NPRPs. The latter often operate out of just
one or two rooms, and their staff have lower-level health
qualiﬁcations, such as nurse assistant or pharmacy technician
[13]. Pharmacies are more common in urban areas, whereas
NPRPs operate mainly in rural and peri-urban areas. In SSA,
such drug shops are often the most widely used source of
medicine, providing an alternative avenue through which
essential treatments can be provided to the public.
Although SDSs remain popular, there is evidence of regu-
latory infringements such as dispensing prescription medi-
cines without prescription and selling sub-therapeutic
quantities of drugs [9, 14]. To address such inadequacies, a
range of interventions have been implemented. We
conducted this review to assess the effectiveness of interven-
tions for improving the quality of services provided by SDSs
in SSA. We focus on SSA given the distinctive nature of its
retail pharmaceutical sector due to the small number of
trained pharmacists and the large role of NPRPs.
Review methodology
Scope of review and methods for identiﬁcation of
studies
Black and Gruen [15] categorized interventions for improv-
ing the quality of health services into six areas: education,
feedback, incentives, reorganizing administrative structures,
regulation and legislation. We adopted the Black and Gruen
classiﬁcation in this review for its breadth, thus allowing us
to develop a comprehensive search strategy. We excluded
studies targeting general shops, community-owned shops and
pharmacies located within health facilities. We considered pri-
marily randomized controlled trials (RCTs), interrupted time-
series studies and before and after studies. We included
uncontrolled before and after (UBA) studies alongside the
more rigorous controlled before and after (CBA) designs due
to the limited number of evaluations overall. Finally, we con-
sidered evaluations reporting any objective outcome related
to improvement in the quality of services provided by the
shops.
An exploratory PubMed search facilitated identiﬁcation of
search terms and elaboration of a search strategy (Table 1),
which we subsequently applied to PubMed, CAB Abstracts,
Web of Science, PsycINFO, id21 and Eldis databases. We
searched websites for the International Network for the
Rational Use of Drugs, e-Drug, WHO Essential Medicines
and Management Sciences for Health for references to rel-
evant articles. We conducted cited-reference searches in the
Web of Science database to identify studies written by experts
on the topic and those citing other relevant studies. Finally, we
searched manually through references of all retrieved articles.
.............................................................................................................................................................................
Table 1 Search terms applied in electronic databases
Group A: target population
(combined by ‘OR’)
Group B: geographic location
(combined by ‘OR’)
Group C: interventions (combined by ‘OR’)
drug retailer* Third World Countr* feedback
medicine retailer* Less-Developed Countr* educat*, train*
pharmacy Sub-Saharan Africa* regulat*, accred*, licens*, certiﬁcat*
pharmacies low-and middle income countr* legisl*
drug shop* Developing countries [MeSH] inspect*
medicine shop* Africa South of the Sahara [MeSH] motivat*, incentiv*
drug seller* [List of Sub-Saharan African countries] supervis*
medicine seller* peer inﬂuenc*
drug vendor* Feedback [MeSH]
medicine vendor* Education [MeSH]
drug store* Social Control, Formal [MeSH]
medicine store* Government Regulation [MeSH]
Pharmacies [MeSH] Facility Regulation and Control [MeSH]
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The search initially identiﬁed 557 articles (ﬁnal search: 15
April 2009), of which 548 were discarded for failure to meet
the review criteria. The remaining nine articles, reporting 10
studies, were all included. We extracted information on study
design features, participants, interventions and main out-
comes and assessed each study for methodological quality
using EPOC guidelines (http://www.epoc.cochrane.org/en/
handsearchers.html; Table 2). Areas assessed included the
randomization processes (for RCTs), blinding of outcome
assessors (where applicable), completeness of follow-up of
participants, presence of baseline measurement and protec-
tion against contamination. Finally, we extracted results and
reported key outcomes (Table 3). The studies were hetero-
geneous in terms of interventions and outcomes, making
attempts to calculate overall effect sizes inappropriate.
Consequently, we undertook a structured narrative synthesis.
Results
Study characteristics
There was one RCT [16], one non-randomized single-site
cross-over study [17] and eight before and after studies, four
having contemporaneous controls [18–21] and four having
no controls [7, 22, 23]. Four evaluations were conducted in
Nigeria, two each in Ghana and Uganda, and one each in
Tanzania and Kenya. Eight studies were conducted after the
year 2000. Five evaluations targeted PRPs exclusively [7, 17,
18, 20, 23], whereas four focused on NPRPs [16, 19, 22].
One study included both PRPs and NPRPs [21]. Education
was the primary intervention in all 10 studies, with seven
describing the provision of information, education and com-
munication (IEC) materials as part of the intervention. In
one evaluation, training was implemented through nego-
tiation sessions between moderators and patent medicine
vendors (PMVs) [22]. Only four studies described the train-
ing sessions as interactive [16, 20–22]; the rest did not ade-
quately describe the training model. No evaluations of the
other ﬁve intervention types were identiﬁed, although the
negotiation-based training model implemented in Uganda
can also be classiﬁed under ‘feedback’. The simulated client
methodology was used, either alone or alongside question-
naire surveys, to assess SDS practices in 8 of the 10 evalu-
ations. Only Oparah et al. and Aguwa et al. did not use
simulated clients.
With regard to the study quality, all 10 studies had baseline
measurements. Follow-up of participants was well-described
and relatively high (over 80% generally) in majority of
studies. All four CBA studies described the characteristics of
control sites, a practice recommended by EPOC. On the
other hand, the RCT neither described randomization pro-
cesses nor explained whether or how protection against con-
tamination was done. The study did, however, report
blinding of outcome assessors.
The studies were considerably heterogeneous in the out-
comes they reported (Table 3). Eight reported outcomes on
knowledge of disease signs and symptoms [16, 17, 19–23],
seven on communication with clients [16, 18–22], six on
treatment of diseases [7, 16, 18, 21, 22], four on patient refer-
ral [7, 21, 22], three reported changes in selling of certain
medicines [16, 20, 21] and two reported on costs of medicines
[7, 18]. None reported on the cost-effectiveness of the inter-
ventions. Eight studies used tracer diseases of infectious
origin. These were malaria (reported in three studies), STIs [3],
ARIs [3], diarrhoea [3] and colds and guinea worm (one study
each). The two evaluations that did not include tracer infec-
tious diseases used hypertension [17, 23]. Evaluation periods
varied across studies with three doing evaluations immediately
or 1 month post-intervention [19–21], six after 2–6 months
[16–18, 22, 23] and one after 1y e a r[ 7]. None of the
studies had evaluation periods longer than 1 year.
Study ﬁndings
Knowledge of attendants. An evaluation in Kenya reported
improvement in pharmacy attendants’ knowledge on
appropriateness of antibiotics for diarrhoea and signs of
bacterial diarrhoea following an educational intervention (P,
0.05 in both) [20]. Two evaluations done 12 years apart also
reported improvement in the knowledge of PMVs in Nigeria.
The ﬁrst evaluation found improvement in knowledge scores
on management and referral for various diseases (P, 0.001)
[19], whereas the latter reported improved knowledge on signs
of severe malaria and ways of preventing the disease (P,
0.01) [22]. In Tanzania, trained attendants performed better in
8 of 10 questions testing knowledge on antimalarials,
antibiotics and diarrhoea medicines and measures for reducing
fever in children (P, 0.01) [16].
Communication with clients. There was improvement in
counselling of STI patients on partner notiﬁcation in Ghana
(P , 0.05) [18], and taking patient history and providing
advice on use of insecticide-treated bednets (ITNs) in
Nigeria and Uganda (P , 0.01 in both) [22]. In another
Nigerian evaluation, the proportion of PMVs indicating that
they could explain medication use to clients increased after
training, although inference values were not provided [19]. In
Tanzania, 95% of attendants from intervention shops asked
about sick children’s age compared with 60% in the control
(P , 0.01) [16]. The same study reported better
post-intervention performance in inquiring about sick
children’s symptoms and duration of illness before
recommending treatment (P , 0.01).
On the other hand, education failed to increase the
number of questions clients seeking care for diarrhoea in
Kenyan pharmacies were asked [20] and did not improve
history taking for ARI in Ugandan pharmacies and drug
shops [21]. The latter study also failed to report improve-
ment in provision of medication instructions to caregivers. In
Ghana, training did not signiﬁcantly improve counselling of
STI patients on condom use [18].
Treatment and referral of patients. Educational interventions
signiﬁcantly reduced inappropriate dispensing of medicines
in Tanzania, Kenya and Nigeria [16, 20, 22]. In Kenya, the
sale of anti-diarrhoeal medicines (not usually recommended)
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Table 2 Description and methodological quality of studies
Ref.
No.
Study Location Design Participants
(number evaluated)
Intervention Methodological quality
18 Adu-Sarkodie et al.
(2000)
Ghana CBA Pharmacies (n ¼ 100) Training staff on STIs BL-done, B-done, PC-nc,
CC-done, F/U-done
17 Aguwa and Ukwe
(2008)
Nigeria Cross-over Patients visiting one
pharmacy (n ¼ 24)
Training pharmacy staff on pharmaceutical care BL-done, B-nd, F/U-nc
22 Greer et al. (2004) Nigeria UBA Patent medicine vendors
(n ¼ 247)
Training, IEC materials, certiﬁcation, public
education, launch of pre-packed antimalarials
BL-done, F/U-done, B-N/A
22 Greer et al. (2004) Uganda UBA Patent medicine vendors
(n ¼ 138)
Negotiating behaviour change for management of
fever in children
BL-done, F/U-nc, B-N/A
7 Mayhew et al. (2001) Ghana UBA Pharmacies (n ¼ 248) Training (1 day) on STIs BL-done, F/U-done; B-N/A
16 Nsimba (2007) Tanzania RCT Drug shops (n ¼ 40) Training, IEC materials, control received IEC only AC-nc, F/U-nc, B-nc,
BL-done, PC-nc
23 Oparah et al. (2006) Nigeria UBA Patients visiting one
pharmacy (n ¼ 36)
Training pharmacy staff on pharmaceutical care BL-done, F/U-nc, B-N/A
19 Oshiname and
Brieger (1992)
Nigeria CBA Patent medicine vendors
(n ¼ 37)
Training on counselling, signs, prevention and
referral
BL-done, B-nd, PC-nc, F/
U-nc, CC-done
20 Ross-Degnan et al.
(1996)
Kenya CBA Pharmacies (n ¼ 107) IECs and face-to-face educational outreaches BL-done, B-done, F/U-done,
PC-done, CC-done
21 Tumwikirize et al.
(2004)
Uganda CBA Pharmacies and drug shops
(n ¼ 191)
Face-to-face training and IEC materials BL-done, B-nc, PC-nc,
CC-done, F/U-done
CBA, controlled before and after; UBA, uncontrolled before and after; RCT, randomized controlled trial; AC, allocation concealment; B, blinding; BL, baseline; CC, characteristics of controls
described; F/U, follow-up; nc, not clear; N/A, not applicable; PC, protection against contamination.
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Table 3 Summary of study ﬁndings
Ref.
No.
Study (year) Study outcomes (evaluation period) No. of measures (No.
signiﬁcant at P , 0.05)
Key signiﬁcant outcomes
18 Adu-Sarkodie et al
(2000)
Management of STI (6–8 months) 3 (3) Improvement in partner notiﬁcation, counselling on condoms and
proper treatment of STIs
17 Aguwa and Ukwe
(2008)
Patient compliance, blood pressure,
lifestyle, knowledge and client satisfaction
(5 months)
15 (9) Improvement in blood pressure, lifestyle, knowledge on disease,
adherence to drugs, detection of drug problems, physical health and
social relationships
22 Greer et al (2004) Uptake of pre-packaged drugs,
knowledge, communication and treatment
(4 months)
25 (21) Improvement in knowledge on bednets, signs and symptoms of severe
childhood illness, history taking and giving correct treatment for
malaria in children
22 Greer et al (2004) Advice on correct medicine and dose,
ITN use, history taking and referral
(2 months)
12 (7) Improvement in recommending right drug and dose, giving
instructions on how to take drugs for simple malaria, advising on
ITNs and referring patients
7 Mayhew et al
(2001)
Management of STI (1 year) 10 (not clear) Improvement in managing urethral discharge, some improvement in
patient referral, little change in management of genital ulcers and
related conditions
16 Nsimba, E (2007) Use of national treatment guidelines
(6 months)
10 (not clear) Improvement in providing correct treatment for diarrhoea, ARI, colds
and fever
23 Oparah et al (2006) Patient compliance, blood pressure,
knowledge and satisfaction (6 months)
56 (not clear) Improvement in blood pressure, compliance scores, knowledge on
hypertension and risk factors, and patient satisfaction
19 Oshiname and
Brieger (1992)
Knowledge on signs, counselling and
prevention (immediate)
2 (2) Pre- and post-improvement in overall questionnaire score in the
intervention arm; post-training improvement in intervention arm
signiﬁcant compared to control
20 Ross-Degnan et al
(1996)
Knowledge, communication and sales
(2–4 weeks)
21 (10) Improvement in knowledge on causes, treatment and referral of
diarrhoea; selling of appropriate drugs and communication with
patients on diarrhoea
21 Tumwikirize et al
(2004)
Patient assessment and, dispensing
practices of pharmacies and drug shops
(1 month)
28 (3) Improvement in asking questions on cough, prescribing correct
antibiotic for ARI and reduced dispensing of cough syrups. No
improvement in majority of outcomes
W
a
f
u
l
a
a
n
d
G
o
o
d
m
a
n
3
2
0declined, with the reduction among pharmacies within the
capital city (Nairobi) being signiﬁcant at the 95% level
(219%; 95% CI: 236 to 23), whereas in Tanzania, 85% of
clients who visited intervention shops got an appropriate
antimalarial drug compared with 55% in the control group
(P , 0.01). The latter study also reported reduction in the
inappropriate sale of antibiotics for cough, although the
decline corresponded with a large increase in the sale of
cough mixtures (80% increase in intervention shops
compared with 20% in the control) [16]. Whereas the
number of PMVs recommending correct doses of
antimalarials increased from 9% to 53% in Nigeria (P,
0.01), fewer attendants recommended correct treatments for
both simple and complicated malaria after negotiations
sessions in Uganda (P , 0.01 in both cases) [22]. Another
Ugandan evaluation found education effective in improving
the dispensing of antibiotics for severe ARI (P ¼ 0.001),
although a concomitant decline in referral of severely ill
children (P ¼ 0.004) pointed to the possibility that by
improving attendants’ knowledge, the intervention
inadvertently resulted in more shops treating, rather than
referring severely ill children as required by policy [21].
Opposite trends were reported in Ghana, Nigeria and
elsewhere in Uganda, with staff referring patients more
readily post-intervention. Trained PMVs referred severely ill
patients more frequently in Nigeria and Uganda [22],
whereas in Ghana, they were more likely to refer patients
with genital ulcers [7]. With regard to sale of medicines,
education reduced the sale of antimalarials without
prescription in Tanzania, although the practice remained
prevalent overall at 43% and 80% in intervention and
control shops, respectively [16]. The same evaluation
underscored the impact of client demand on dispensing
practices. Simulated clients were three times more likely to
get a drug they requested if they visited a control rather than
intervention shop (36% compared with 13%; no P-values),
suggesting that education may have empowered sellers to
refuse client requests for drugs in certain instances.
Patient-based outcomes. An evaluation of a pharmaceutical
care intervention for hypertensive patients visiting a
pharmacy in Nigeria, reported improved patient satisfaction
in two domains; ‘friendly explanation’ and ‘managed care’
[23]. A similar study elsewhere in Nigeria reported
improvement in health-related quality of life scores for
hypertensive patients, particularly in the domains of ‘physical
health’ and ‘social relationships’, following implementation of
pharmaceutical care training [17]. Both evaluations further
reported improvement in patient compliance-rated scores
(P ¼ 0.001 for Aguwa et al. and P ¼ 0.006 for Oparah et al.),
signifying post-intervention improvement in compliance to
treatment. Finally, patient knowledge on risk factors,
drug-related problems and management of hypertension
improved signiﬁcantly following the intervention in both
studies. This presumably contributed to improvement in
patient satisfaction and quality of life scores.
Amount of money spent on medicines. There were no signiﬁcant
differences between intervention and control groups with
regard to the amount of money spent purchasing medicines
in Ghanaian pharmacies [18]. Similarly, another evaluation in
Ghana reported no signiﬁcant differences in prices of
medicines before and after training [7].
Discussion
Recent years have witnessed increased recognition of the
importance and inadequacies of SDS in public health, with
several interventions being implemented to improve their
performance across a wide range of disease areas and
countries [24, 25]. This increase in recognition is reﬂected in
the review, with 8 of the 10 evaluations having been con-
ducted over the last decade. Although the complete absence
of evaluations from Francophone states may reﬂect a weak-
ness in our search strategy, it is more likely that there are few
evaluations on the topic from these countries overall, an
observation also made in a previous review on a related
topic [13]. This could be a reﬂection of more negative atti-
tudes towards less qualiﬁed providers on the part of the
medical communities in these countries.
Interventions have been directed at improving outcomes
such as attendant knowledge and practices, with majority tar-
geting pharmacies rather than drug shops, despite the fact
that the latter form the vast majority of SDSs in SSA [13].
Of the six types of interventions introduced earlier, only edu-
cation has been implemented in SSA according to articles
reviewed. The popularity of training as an intervention for
pharmacies is reﬂected in another review that focused more
broadly on developing countries, although regulation and
peer review were reported to be fairly common as well [25].
The preference for combining training and IEC materials
concurs with ﬁndings from a review that found multi-faceted
interventions more effective than stand-alone ones [26].
Majority of studies used simulated clients to study practices
of SDSs, reﬂecting the advantages of this method in mini-
mizing observer bias [27, 28].
The relatively small number of evaluations included in this
review may not reﬂect the number of initiatives implemented
to improve the impact of SDSs. Other initiatives launched in
recent years include Accredited Drug Dispensing Outlets
(ADDOs) in Tanzania [29], CareShops in Ghana [30] and
clinical social franchising initiatives including BlueStar and
ProFam programmes in several African states [31]. However,
evaluations meeting our inclusion criteria were not identiﬁed
for these programmes.
Aside from the overall scarcity of studies on the topic,
there are concerns over how well evaluations were con-
ducted. The RCT article failed to adequately describe key
processes such as randomization and controlling for con-
tamination, making it difﬁcult to infer quality of evidence.
CBA and UBA study designs were better reported, with all
having baseline measurements and CBA studies having some
description of characteristics of control sites. However, the
relatively short follow-up periods remains a major concern,
as it makes it difﬁcult to gauge long-term effectiveness of
educational interventions for SDSs. Furthermore, evaluations
targeting staff with different levels of training failed to
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cadres, thus making it difﬁcult to identify staff with the great-
est potential to beneﬁt. Lastly, the limited number of evalu-
ations, coupled with wide variations in reporting outcomes,
made it inappropriate to analyse patterns of effects across
geographical location, disease types or length of follow-up
periods.
Despite the limitations described, it is possible to draw
some tentative conclusions. The general improvement in
outcome indicators across majority of studies suggests that
knowledge and practices of SDS staff can be improved
through education. Although majority of studies showed
mixed results across outcomes, ﬁndings related to change in
knowledge were positive across all studies, indicating that
education does improve knowledge of SDS attendants. With
regard to communication, there was improvement in counsel-
ling and advising of patients overall. However, ﬁndings on
patient history taking were mixed, with success in Tanzania,
but not Uganda for instance. This discrepancy could not be
explored further due to the limited number of studies.
Another inconsistency that could not be explored in-depth
was the impact the client demand has on practices of attend-
ants. Whereas one evaluation inferred that education can sig-
niﬁcantly reduce the likelihood of attendants acceding to
client demands, another study found it ineffective in
encouraging attendants to question clients seeking to buy
medicines without prescription. With regard to providing rec-
ommended treatments, education was beneﬁcial in majority
of evaluations. However, it also emerged that there could
potentially arise conﬂict between policy objectives if pro-
posed roles of SDSs vis-a `-vis other providers were not
clearly outlined at the onset. In this review for instance, edu-
cation improved attendants’ choice of treatments for severe
ARI in Ugandan children, but inadvertently resulted in more
shops opting to treat rather than refer the severely ill chil-
dren. Such task-shifting phenomena could happen in cases
where objectives of interventions are not clearly spelt out at
the outset. The need to tailor interventions to reﬂect broader
policy objectives with regard to the roles of retailers has been
voiced in another review looking at interventions for improv-
ing malaria treatment in children [24].
The importance of proﬁt among SDSs was underscored
in the Tanzanian study, where a decline in the sale of anti-
biotics for cough corresponded with an increase in the sale
of cough mixtures, despite the fact that such multi-ingredient
preparations have unproven efﬁcacy. Such perverse beha-
viours (substituting between products) could nullify policy
gains if not adequately considered when designing interven-
tions for private-for-proﬁt groups. Proﬁt may also have been
a constraining factor in Kenya and Uganda, where shop
attendants dispensed treatments without asking appropriate
questions. Although proﬁt incentives appeared to constrain
positive change or encourage perverse outcomes, there were
cases of SDSs adopting practices that seemed to reduce
sales. In Uganda, Nigeria and Ghana, for instance, increased
referral rates were reported post-intervention, and in
Tanzania, trained sellers were less likely to accede to client
requests for medicines. These outcomes highlight the
importance of factors beyond proﬁt incentives in inﬂuencing
practices of SDSs [32]. Although ﬁndings of this nature may
be particularly encouraging, short evaluation periods make
assessment of sustainability difﬁcult.
More evaluations need to focus on other interventions
such as regulation, incentives and peer-review strategies.
Studies also need to focus on non-pharmacy types of SDSs
frequently found in rural areas of SSA. These shops, whose
legal stature varies from country to country, are not acknowl-
edged by some governments, despite their role as the
primary de facto providers of medicines and treatment advice
in majority of rural areas. Finally, the overriding issue of a
general lack of independent and rigorous impact evaluations
needs to be addressed to ensure policymakers and develop-
ment partners invest in programs that actually work.
Conclusion
There is evidence that knowledge and practices of SDSs can
be improved across a wide range of diseases and geographi-
cal areas, although there were variations across studies. Proﬁt
incentives appear to inﬂuence the success of educational
interventions in some, but not all cases. However, outcome
patterns could not be explored across studies in detail due to
the limited number of studies overall. Further evaluations are
needed to extend the geographical base of evidence, investi-
gate cost-effectiveness, determine sustainability of interven-
tions over longer periods and evaluate other types of
interventions.
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